본문 바로가기
KERD
논문KCI 등재

Outcomes of conventional transarterial chemoembolization using guidance software for hepatocellular carcinoma in the caudate lobe of the liver

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background: To evaluate the outcomes of conventional transarterial chemoembolization (TACE) using guidance software for hepatocellular carci-noma (HCC) in the caudate lobe.Methods: Seventy-two patients with 79 treatment-naïve caudate lobe HCCs were eligible. TACE was performed through feeders not only identified by automated tumor-feeder detection (AFD) functionality but also detected manually. Technical success of TACE was classified into three grades accord-ing to 1-week computed tomography findings: entire tumor embolized with a safety margin (5 mm for tumors < 25 mm and 10 mm for tumors ≥ 25 mm) (grade A); tumor embolized without a margin in parts (grade B); and entire tumor not embolized (grade C). Tumor response was evaluated using the modified Response Evaluation Criteria in Solid Tumors. Tumor-feeder detectability by AFD, technical success of TACE, complete response (CR) at 2–4 months, durable CR, and local tumor progression (LTP) rates calculated by the Kaplan-Meier method were compared in each tumor among three subsegments: the Spiegel lobe (SP); paracaval portion (PC); and caudate process (CP). LTP rates between the grade A and B tumors were also com-pared.Results: The mean tumor diameter was 18.6 ± 9.9 mm (range, 6–53 mm), and 111 of 129 (86.0%) tumor feeders were detected by AFD. The rates of feeder detectability by AFD, grade A technical success of TACE, CR at 2–4 months, and durable CR in 30 SP, 38 PC, and 11 CP tumors were 71.4%, 93.3%, 93.1%, and 79.3%; 94.8%, 65.8%, 59.4%, and 34.4%; and 76.5%, 63.6%, 80.0%, and 30.0%, respectively. LTP rates of SP tumors were sig-nificantly lower than those of PC tumors (P = 0.0044), and the grade B tumors progressed more frequently (P = 0.0012).Conclusion: AFD could detect 86.0% of tumor feeders in the caudate lobe; however, the feeder detectability, technical success of TACE, and outcomes differed among the three subsegments.

Abstract

Background: To evaluate the outcomes of conventional transarterial chemoembolization (TACE) using guidance software for hepatocellular carci-noma (HCC) in the caudate lobe.Methods: Seventy-two patients with 79 treatment-naïve caudate lobe HCCs were eligible. TACE was performed through feeders not only identified by automated tumor-feeder detection (AFD) functionality but also detected manually. Technical success of TACE was classified into three grades accord-ing to 1-week computed tomography findings: entire tumor embolized with a safety margin (5 mm for tumors < 25 mm and 10 mm for tumors ≥ 25 mm) (grade A); tumor embolized without a margin in parts (grade B); and entire tumor not embolized (grade C). Tumor response was evaluated using the modified Response Evaluation Criteria in Solid Tumors. Tumor-feeder detectability by AFD, technical success of TACE, complete response (CR) at 2–4 months, durable CR, and local tumor progression (LTP) rates calculated by the Kaplan-Meier method were compared in each tumor among three subsegments: the Spiegel lobe (SP); paracaval portion (PC); and caudate process (CP). LTP rates between the grade A and B tumors were also com-pared.Results: The mean tumor diameter was 18.6 ± 9.9 mm (range, 6–53 mm), and 111 of 129 (86.0%) tumor feeders were detected by AFD. The rates of feeder detectability by AFD, grade A technical success of TACE, CR at 2–4 months, and durable CR in 30 SP, 38 PC, and 11 CP tumors were 71.4%, 93.3%, 93.1%, and 79.3%; 94.8%, 65.8%, 59.4%, and 34.4%; and 76.5%, 63.6%, 80.0%, and 30.0%, respectively. LTP rates of SP tumors were sig-nificantly lower than those of PC tumors (P = 0.0044), and the grade B tumors progressed more frequently (P = 0.0012).Conclusion: AFD could detect 86.0% of tumor feeders in the caudate lobe; however, the feeder detectability, technical success of TACE, and outcomes differed among the three subsegments.

참고문헌 (31)

  1. Terayama N, "Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe", J Vasc Interv Radiol, 9, pp.501~508 (1998)
  2. Yoon CJ, "Hepatocellular carcinoma in the caudate lobe of the liver : angiographic analysis of tumor-feeding arteries according to subsegmental location", J Vasc Interv Radiol, 19, pp.1543~1550 (2008)
  3. Miyayama S, "Hepatocellular carcinoma in the caudate lobe of the liver : variations of its feeding branches on arteriography", Jpn J Radiol, 28, pp.555~562 (2010)
  4. Kim HC, "Caudate lobe hepatocellular carcinoma treated with selective chemoembolization", Radiology, 257, pp.278~287 (2010)
  5. Miyayama S, "Angiographic evaluation of feeding arteries of hepatocellular carcinoma in the caudate lobe of the liver", Cardiovasc Intervent Radiol, 34, pp.1244~1253 (2011)
  6. Kim HC, "Selective chemoembolization of caudate lobe hepatocellular carcinoma : anatomy and procedural techniques", Radiographics, 39, pp.289~302 (2019)
  7. Miyayama S, "Arterial blood supply to the caudate lobe of the liver from the proximal branches of the right inferior phrenic artery in patients with recurrent hepatocellular carcinoma after chemoembolization", Jpn J Radiol, 30, pp.45~52 (2012)
  8. Miyayama S, "Blood supply to the caudate lobe of the liver from the right inferior phrenic artery : observation by cone-beam computed tomography during arteriography", Abdom Radiol(NY), 45, pp.2851~2861 (2020)
  9. Takayasu K, "Clinical and radiologic features of hepatocellular carcinoma originating in the caudate lobe", Cancer, 58, pp.1557~1562 (1986)
  10. Miyayama S, "Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography", Cardiovasc Intervent Radiol, 32, pp.255~264 (2009)
  11. Miyayama S, "Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography", Cardiovasc Intervent Radiol, 37, pp.388~395 (2014)
  12. Choi WS, "Role of C-arm CT in identifying caudate arteries supplying hepatocellular carcinoma", J Vasc Interv Radiol, 25, pp.1380~1388 (2014)
  13. Deschamps F, "Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor : a pilot study", Cardiovasc Intervent Radiol, 33, pp.1235~1242 (2010)
  14. Iwazawa J, "Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization", Eur J Radiol, 82, pp.1665~1671 (2013)
  15. Minami Y, "Tracking navigation imaging of transcatheter arterial chemoembolization for hepatocellular carcinoma using threedimensional cone-beam CT angiography", Liver Cancer, 3, pp.53~61 (2014)
  16. Miyayama S, "Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization", J Vasc Interv Radiol, 24, pp.501~508 (2013)
  17. Miyayama S, "Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software : technical success and short-term tumor response", Abdom Imaging, 39, pp.645~656 (2014)
  18. Miyayama S, "Outcomes of patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization using guidance software", J Vasc Interv Radiol, 30, pp.10~18 (2019)
  19. Miyayama S, "Usefulness of virtual parenchymal perfusion software visualizing embolized areas to determine optimal catheter position in superselective conventional transarterial chemoembolization for hepatocellular carcinoma", Hepatol Res, 51, pp.313~322 (2021)
  20. Pung L, "The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma : a systematic review and meta-analysis", J Vasc Interv Radiol, 28, pp.334~341 (2017)
  21. Miyayama S, "Efficacy of superselective conventional transarterial chemoembolization using guidance software for hepatocellular carcinoma within three lesions smaller than 3cm", Cancers(Basel), 13, pp.6370~ (2021)
  22. Kumon M, "Anatomy of the caudate lobe with special reference to portal vein and bile duct", Kanzo, 26, pp.1193~1199 (1985)
  23. Tanaka S, "Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe", Am J Surg, 190, pp.451~455 (2005)
  24. Shibata T, "Efficacy of nonsurgical treatments for hepatocellular carcinoma in the caudate lobe", Cardiovasc Intervent Radiol, 25, pp.186~192 (2002)
  25. Seror O, "Radiofrequency ablation for the treatment of liver tumors in the caudate lobe", J Vasc Interv Radiol, 16, pp.981~990 (2005)
  26. Yamakado K, "Percutaneous radiofrequency ablation for the treatment of liver neoplasms in the caudate lobe left of the vena cava : electrode placement through the left lobe of the liver under CTfluoroscopic guidance", Cardiovasc Intervent Radiol, 28, pp.638~640 (2005)
  27. Tohma T, "Communicating arcade between the right and left hepatic arteries : evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery", Radiology, 237, pp.361~365 (2005)
  28. Miyayama S, "Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma", Cardiovasc Intervent Radiol, 33, pp.1168~1179 (2010)
  29. Miyayama S, "Arterial blood supply to the posterior aspect of segment IV of the liver from the caudate branch : demonstration at CT after iodized oil injection", Radiology, 237, pp.1110~1114 (2005)
  30. Miyayama S, "Blood supply of the main bile duct from the caudate artery and medial subsegmental artery of the hepatic artery : Evaluation using images obtained during transcatheter arterial chemoembolization for hepatocellular carcinoma", Hepatol Res, 43, pp.1175~1181 (2013)
  31. Kogure K, "The caudate processus hepatic vein : a boundary hepatic vein between the caudate lobe and the right liver", Ann Surg, 247, pp.288~293 (2008)

관련 논문AI추천

A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads김현, 김영남, 김진동, 송경호, 송하헌, 이상진, 이정록, 전원중, 조동후, 차병효대한간학회 · Clinical and Molecular Hepatology2010 · 제16권 제4호Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization김부성, 김상균, 김영석, 김용권, 김용재, 김홍수, 박수연, 백민영, 유정주, 이세환, 장재영, 정승원, 정신옥, 조영덕, 차상우대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제6호Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma구동억, 김보성, 김상균, 김영석, 김용재, 김의배, 김홍수, 박수연, 이세환, 장재영, 정승원, 정신옥, 차상우, 최영덕거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제3호Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolizationKeerati Hongsakul, Kittipitch Bannangkoon, Teeravut Tubtawee, Teerha Piratvisuth대한간학회 · Clinical and Molecular Hepatology2019 · 제25권 제1호The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE강원석, 고광철, 곽금연, 김정희, 백승운, 백용한, 신동현, 신성욱, 이준혁, 조성기, 최문석대한간학회 · Clinical and Molecular Hepatology2017 · 제23권 제1호Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in JapanHiroki Higashihara, Kaisyu Tanaka, Kosuke Tomotake, Noriyuki Tomiyama, Yusuke Ono소화기인터벤션의학회 · International Journal of Gastrointestinal Intervention2021 · 제10권 제4호

이 간행물의 다른 논문 (8건)